Blood filter during urgent heart surgery for patients on blood thinners
Part of Heart & circulation clinical trials.
This trial tests a device that filters the blood during urgent heart surgery. It may help patients who take blood thinners by reducing bleeding risks during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having urgent (non-elective) heart surgery that uses a heart-lung machine
- You are taking one of these blood thinners: indobufen, ticagrelor, warfarin, cilostazol, dabigatran, rivaroxaban, or apixaban
- Your last dose of the blood thinner was within the usual waiting period before surgery
- You do not have severe liver or kidney disease, and you do not need routine dialysis
- You are not pregnant or in the postpartum period
- You do not have a bleeding disorder like heparin-induced thrombocytopenia, hemophilia, or sickle cell disease in crisis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
This study tests a special filter (called Cytosorb) that may reduce bleeding during heart surgery by capturing the blood thinner ticagrelor from your blood. If you take ticagrelor and are scheduled for heart surgery with a bypass machine, this filter could help lower your risk of bleeding.
This study tests whether adding a special filter (called a cytokine adsorber) to the heart-lung machine during your child's open-heart surgery can reduce harmful inflammation and help them recover better. The filter is used alongside the standard heart-lung machine during the operation.
This trial tests a special blood filter used during children's heart surgery to reduce inflammation. It may help children recover faster after long operations.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This study tests a blood-filtering treatment that may help remove harmful substances from the blood in people with sepsis. It might improve recovery for patients in the intensive care unit (ICU).
Hear when a new CABG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.